Publications by the researcher in collaboration with Jordi Xercavins Montosa (18)

2013

  1. Molecular diagnosis of endometrial cancer from uterine aspirates

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2383-2391

2012

  1. Erratum: Molecular markers of endometrial carcinoma detected in uterine aspirates (International Journal of Cancer (2011) 129:11 (2435-2444) DOI: 10.1002/ijc.25901)

    International Journal of Cancer

  2. Generation and characterization of orthotopic murine models for endometrial cancer

    Clinical and Experimental Metastasis, Vol. 29, Núm. 3, pp. 217-227

  3. Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

    Molecular and Cellular Endocrinology, Vol. 358, Núm. 2, pp. 244-255

  4. The EMT signaling pathways in endometrial carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720

2011

  1. Molecular markers of endometrial carcinoma detected in uterine aspirates

    International Journal of Cancer, Vol. 129, Núm. 10, pp. 2435-2444

2009

  1. An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis

    International Journal of Cancer, Vol. 125, Núm. 2, pp. 257-263

  2. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress

    Carcinogenesis, Vol. 30, Núm. 8, pp. 1288-1297

  3. Proteomic approach to endometrial carcinoma invasion front

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 147-147

  4. Subtractive proteomic approach to the endometrial carcinoma invasion front

    Journal of Proteome Research, Vol. 8, Núm. 10, pp. 4676-4684

2008

  1. Novel molecular profiles of endometrial cancer-new light through old windows

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 108, Núm. 3-5, pp. 221-229

2007

  1. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer

    Cancer Research, Vol. 67, Núm. 14, pp. 6753-6759

  2. ETV5 i RUNX1, nous factors de transcripció implicats en la invasió miometrial del carcinoma endometrial

    Treballs de la Societat Catalana de Biologia, Núm. 56, pp. 243-255

  3. Molecular determinants of invasion in endometrial cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 272-277

2006

  1. Molecular pathology of endometrial carcinoma: Transcriptional signature in endometrioid tumors

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 197-204

  2. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma

    Human Pathology, Vol. 37, Núm. 8, pp. 1050-1057

2005

  1. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma

    Journal of Pathology, Vol. 207, Núm. 4, pp. 422-429

2004

  1. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma

    Cancer Research, Vol. 64, Núm. 24, pp. 8846-8853